"AI in Life Sciences" explores the intersect of artificial intelligence (AI) and healthcare this week. We start with a discussion on the ABOUT Healthcare's merger with Edgility which it is hoped will usher in a new era of care orchestration solutions, utilizing AI and predictive analytics to optimize hospital operations and improve patient care. We then celebrate an unprecedented regulatory move in blood disorder diagnosis with Scopio Labs' FDA De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) Application, a software that digitizes the analysis of bone marrow aspirate with the help of AI. Our next story analyses the abilities of Innovaccer's latest healthcare data activation platform, HXP. Born after Innovaccer's acquisition of Cured, this platform uses AI to engage patients and expedite revenue growth. Finally, we wrap up with new developments at GE HealthCare, which recently launched Voluson Signature ultrasound systems that fuse ergonomics with AI, aimed at improving women's healthcare. Tune in to stay updated on how AI continues to refine and revolutionize the healthcare industry.